Literature DB >> 23504585

Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.

Felipe A Castro1, Jill Koshiol, Ann W Hsing, Susan S Devesa.   

Abstract

We evaluated incidence patterns of biliary tract cancers (gallbladder, extrahepatic bile duct, ampulla of Vater and not otherwise specified) to provide potential insight into the etiology of these cancers. Data were obtained from the population-based Surveillance, Epidemiology and End Results program. Rates for cases diagnosed during 1992-2009 were calculated by racial/ethnic, gender and age groups. Temporal trends during 1974-2009 and annual percentage changes (APC) during 1992-2009 were estimated. Age-adjusted rates by site were higher among American Indian/Alaska Natives, Hispanics (white) and Asian/Pacific Islanders (Asian/PI) and lower among whites and blacks. Gallbladder cancer was more common among women in all ethnic groups (female-to-male incidence rate ratio [IRR] ranged from 1.24 to 2.86), but bile duct and ampulla of Vater cancers were more common among men (female-to-male IRR 0.57 to 0.82). Gallbladder cancer rates declined among all racial/ethnic and gender groups except blacks (APC -0.4% to -3.9%). In contrast, extrahepatic bile duct cancer rates rose significantly in most female racial/ethnic groups; the APCs among whites were 0.8 among females and 1.3 among males, both significant. Rates for ampulla of Vater cancer decreased among Asian/PI females (APC -2.7%) but remained stable for the other groups. In addition to confirming that biliary tract cancer incidence patterns differ by gender and site and that the gallbladder cancer incidence rates have been declining, our study provides novel evidence that extrahepatic bile duct cancer rates are rising. These observations may help guide future etiologic studies. Published 2013. This article is a US Government work and, as such, is in the public domain of the United States of America.

Entities:  

Keywords:  Klatskin tumors; ampulla of Vater cancer; biliary tract cancer; extrahepatic bile duct cancer; gallbladder cancer; incidence

Mesh:

Year:  2013        PMID: 23504585      PMCID: PMC3713194          DOI: 10.1002/ijc.28161

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  36 in total

1.  Origin of laparoscopic cholecystectomy in the USA: personal experience.

Authors:  J B McKernan
Journal:  World J Surg       Date:  1999-04       Impact factor: 3.352

Review 2.  Cancers of the pancreas and biliary tract: epidemiological considerations.

Authors:  J F Fraumeni
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

3.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

4.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

5.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

6.  Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.

Authors:  Jorge Albores-Saavedra; Kristen Batich; Sarah Hossain; Donald E Henson; Arnold M Schwartz
Journal:  Ann Diagn Pathol       Date:  2009-12       Impact factor: 2.090

7.  Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998.

Authors:  R Wood; L A Fraser; D H Brewster; O J Garden
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

8.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

Authors:  Shahid A Khan; Shireen Emadossadaty; Nimzing G Ladep; Howard C Thomas; Paul Elliott; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

9.  Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.

Authors:  H Nordenstedt; F Mattsson; H El-Serag; J Lagergren
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

10.  Gallstones and the risk of biliary tract cancer: a population-based study in China.

Authors:  A W Hsing; Y-T Gao; T-Q Han; A Rashid; L C Sakoda; B-S Wang; M-C Shen; B-H Zhang; S Niwa; J Chen; J F Fraumeni
Journal:  Br J Cancer       Date:  2007-11-13       Impact factor: 7.640

View more
  35 in total

1.  The value of preoperative screening colonoscopies in patients with biliary tract cancer.

Authors:  Keita Itatsu; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Gen Sugawara; Keisuke Uehara; Takashi Mizuno; Masahiko Ando; Hidemi Goto; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-05-31       Impact factor: 7.527

2.  Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.

Authors:  Junji Ueda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Masato Yoshioka; Atsushi Hirakata; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tomohiro Kanda; Hideyuki Takata; Ryota Kondo; Eiji Uchida
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

3.  Association of Aflatoxin and Gallbladder Cancer.

Authors:  Jill Koshiol; Yu-Tang Gao; Michael Dean; Patricia Egner; Chirag Nepal; Kristine Jones; Bingsheng Wang; Asif Rashid; Wen Luo; Alison L Van Dyke; Catterina Ferreccio; Michael Malasky; Ming-Chang Shen; Bin Zhu; Jesper B Andersen; Allan Hildesheim; Ann W Hsing; John Groopman
Journal:  Gastroenterology       Date:  2017-04-17       Impact factor: 22.682

4.  Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.

Authors:  Haixia Yang; Jiupeng Zhou; Xin Wei; Fan Wang; Huadong Zhao; Enxiao Li
Journal:  Mol Clin Oncol       Date:  2014-08-07

5.  Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.

Authors:  Emma E McGee; Sarah S Jackson; Jessica L Petrick; Alison L Van Dyke; Hans-Olov Adami; Demetrius Albanes; Gabriella Andreotti; Laura E Beane-Freeman; Amy Berrington de Gonzalez; Julie E Buring; Andrew T Chan; Yu Chen; Gary E Fraser; Neal D Freedman; Yu-Tang Gao; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Eric J Grant; Francine Grodstein; Patricia Hartge; Mazda Jenab; Cari M Kitahara; Synnove F Knutsen; Woon-Puay Koh; Susanna C Larsson; I-Min Lee; Linda M Liao; Juhua Luo; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Ulrike Peters; Jenny N Poynter; Mark P Purdue; Kim Robien; Dale P Sandler; Norie Sawada; Catherine Schairer; Howard D Sesso; Tracey G Simon; Rashmi Sinha; Rachael Stolzenberg-Solomon; Shoichiro Tsugane; Renwei Wang; Elisabete Weiderpass; Stephanie J Weinstein; Emily White; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Xuehong Zhang; Bin Zhu; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

6.  Genetic alterations in Japanese extrahepatic biliary tract cancer.

Authors:  Rei Noguchi; Kiyoshi Yamaguchi; Tsuneo Ikenoue; Yumi Terakado; Yasunori Ohta; Naohide Yamashita; Osamu Kainuma; Sana Yokoi; Yoshiaki Maru; Hiroki Nagase; Yoichi Furukawa
Journal:  Oncol Lett       Date:  2017-05-22       Impact factor: 2.967

7.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

8.  Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems.

Authors:  Neda Amini; Gaya Spolverato; Yuhree Kim; Rohan Gupta; Georgios Antonios Margonis; Aslam Ejaz; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2014-10-13       Impact factor: 3.454

9.  Risk of hepatobiliary cancer after solid organ transplant in the United States.

Authors:  Jill Koshiol; Karen Pawlish; Marc T Goodman; Katherine A McGlynn; Eric A Engels
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

Review 10.  Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.

Authors:  Apurva Jain; Lawrence N Kwong; Milind Javle
Journal:  Curr Treat Options Oncol       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.